Qiu LX - Search Results

1

MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.

Mao C, Qiu LX, Zhan P, Xue K, Ding H, Du FB, Li J, Chen Q. Mao C, et al. Among authors: qiu lx. J Cancer Res Clin Oncol. 2010 Jul;136(7):975-9. doi: 10.1007/s00432-009-0742-x. Epub 2009 Dec 10. J Cancer Res Clin Oncol. 2010. PMID: 20012093

2

Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects.

Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Jun;121(3):703-8. doi: 10.1007/s10549-009-0636-2. Epub 2009 Nov 21. Breast Cancer Res Treat. 2010. PMID: 19936916

3

KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies.

Mao C, Qiu LX, Liao RY, Du FB, Ding H, Yang WC, Li J, Chen Q. Mao C, et al. Among authors: qiu lx. Lung Cancer. 2010 Sep;69(3):272-8. doi: 10.1016/j.lungcan.2009.11.020. Epub 2009 Dec 22. Lung Cancer. 2010. PMID: 20022659

4

Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.

Mao C, Wang XW, He BF, Qiu LX, Liao RY, Luo RC, Chen Q. Mao C, et al. Among authors: qiu lx. Breast Cancer Res Treat. 2010 Jul;122(1):259-65. doi: 10.1007/s10549-009-0695-4. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033766

5

Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.

Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Jul;122(2):521-5. doi: 10.1007/s10549-009-0731-4. Epub 2010 Jan 7. Breast Cancer Res Treat. 2010. PMID: 20054636 Review.

6

IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.

Qiu LX, Yao L, Yuan H, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Aug;122(3):867-71. doi: 10.1007/s10549-010-0739-9. Epub 2010 Jan 19. Breast Cancer Res Treat. 2010. PMID: 20084546

7

BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.

Qiu LX, Yao L, Xue K, Zhang J, Mao C, Chen B, Zhan P, Yuan H, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Sep;123(2):487-90. doi: 10.1007/s10549-010-0767-5. Epub 2010 Feb 5. Breast Cancer Res Treat. 2010. PMID: 20135345

8

TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.

Qiu LX, Yao L, Mao C, Chen B, Zhan P, Xue K, Zhang J, Yuan H, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Sep;123(2):563-7. doi: 10.1007/s10549-010-0781-7. Epub 2010 Feb 9. Breast Cancer Res Treat. 2010. PMID: 20143152

9

Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.

Qiu LX, Yao L, Mao C, Chen B, Zhan P, Yuan H, Xue K, Zhang J, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Sep;123(2):543-7. doi: 10.1007/s10549-010-0777-3. Epub 2010 Feb 9. Breast Cancer Res Treat. 2010. PMID: 20143154

10

XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.

Qiu LX, Yao L, Zhang J, Zhu XD, Zhao XM, Xue K, Mao C, Chen B, Zhan P, Yuan H, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Nov;124(1):229-35. doi: 10.1007/s10549-010-0813-3. Epub 2010 Mar 5. Breast Cancer Res Treat. 2010. PMID: 20204500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters